BCG production to increase 3x by the end of this year.
Merck & Co. (TICE® BCG): Sole supplier for the U.S. market since 2012, producing 600,000–870,000 vials annually. They are currently building a new facility to triple capacity by late 2026.
What impact will that have on current treatment?
Interested in more discussions like this? Go to the Bladder Cancer Support Group.
Connect
